DR. ROSINA B. DIXON

Corporate Board Profile

Tech Score: 0/100

ENZON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2003-10-28	Dr. Rosina B. Dixon, has served as a director of the Company since August 1994... During the fiscal year ended June 30, 2003 the Company recorded an aggregate of $104,500 in Independent Directors Fees, a summary of which follows:... Rosina B. Dixon 17,500
2004-10-28	Dr. Rosina B. Dixon (1)(2)(3)(5)(6)(7) ..... 61 1994 Director (1) Member of the Compensation Committee (2) Member of Scientific Advisory Committee (3) Member of the Finance and Audit Committee (5) Member of Governance and Nominating Committee (6) Member of the Strategic Planning Committee During the fiscal year ended June 30, 2004, the Company paid the following fees earned during the year ended December 31, 2003 and for the quarter ended March 31, 2004: Rosina Dixon ................. 32,875 24,375 8,500 719 As of June 30, 2004, the Finance and Audit Committee was comprised of Robert LeBuhn (Chairman), Rolf Classon and Dr. Rosina Dixon. As of June 30, 2004, the Compensation Committee was comprised of Rolf Classon (Chairman), Dr. Rosina Dixon and Dr. David Golde. The Scientific Advisory Committee is comprised of Dr. Rosina Dixon (Chairperson), Robert LeBuhn and Rolf Classon. The Strategic Planning Committee is comprised of Rolf Classon, Robert LeBuhn and Dr. Rosina Dixon. The Governance and Nominating Committee is comprised of Dr. Rosina Dixon (Chairperson), Rolf Classon and Robert LeBuhn.

Filing Date

Source Excerpt

2003-10-28

Dr. Rosina B. Dixon, has served as a director of the Company since August 1994... During the fiscal year ended June 30, 2003 the Company recorded an aggregate of $104,500 in Independent Directors Fees, a summary of which follows:... Rosina B. Dixon 17,500

2004-10-28

Dr. Rosina B. Dixon (1)(2)(3)(5)(6)(7) ..... 61 1994 Director (1) Member of the Compensation Committee (2) Member of Scientific Advisory Committee (3) Member of the Finance and Audit Committee (5) Member of Governance and Nominating Committee (6) Member of the Strategic Planning Committee During the fiscal year ended June 30, 2004, the Company paid the following fees earned during the year ended December 31, 2003 and for the quarter ended March 31, 2004: Rosina Dixon ................. 32,875 24,375 8,500 719 As of June 30, 2004, the Finance and Audit Committee was comprised of Robert LeBuhn (Chairman), Rolf Classon and Dr. Rosina Dixon. As of June 30, 2004, the Compensation Committee was comprised of Rolf Classon (Chairman), Dr. Rosina Dixon and Dr. David Golde. The Scientific Advisory Committee is comprised of Dr. Rosina Dixon (Chairperson), Robert LeBuhn and Rolf Classon. The Strategic Planning Committee is comprised of Rolf Classon, Robert LeBuhn and Dr. Rosina Dixon. The Governance and Nominating Committee is comprised of Dr. Rosina Dixon (Chairperson), Rolf Classon and Robert LeBuhn.

Data sourced from SEC filings. Last updated: 2025-08-30